Drug Research
Moderna to Acquire OriCiro Genomics for $85M
Moderna has announced it will acquire Japan-based DNA supplier OriCiro Genomics K.K (OriCiro) for $85m, marking the US company’s first acquisition since its 2010 launch.
Through...
Drug Research
Capsida Biotherapeutics, Prevail Therapeutics Enter Strategic R&D Alliance
Capsida Biotherapeutics Inc. has entered a multi-year strategic collaboration with Prevail Therapeutics, a wholly owned subsidiary of Eli Lilly and Co., to develop genetic medicines...
Drug Research
Australia Implements New Measure To Lower Cost of Medicines
Millions of Australians will pay up to 29% less for their Pharmaceutical Benefits Scheme (PBS) prescriptions because the maximum PBS co-payment is going down from...
Drug Research
Biognosys and Bruker Form Partnership for Advanced Proteomics CRO...
Bruker Corporation and Switzerland-based Biognosys AGÂ announced a strategic partnership, in which Bruker has made a majority-ownership investment in Biognosys. Financial details were not disclosed. J.P.Morgan...
Drug Research
ASLAN, Thermo Fisher Join To Manufacture High Concentration Formulation...
ASLAN Pharmaceuticals , a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, and Thermo Fisher Scientific Inc, the world leader...
Drug Research
Bristol Myers Squibb Completes Sale of Manufacturing Facility in...
Bristol Myers Squibb has completed the previously announced sale of its manufacturing facility in Syracuse, NY to Lotte Biologics.
The divestiture is part of Bristol Myers...
Drug Research
Hong Kong University Develops Bone Anabolic Therapy Aptamer
The molecular target for bone anabolic therapy has been discovered by a research team headed by Hong Kong Baptist University (HKBU), utilising a particular aptamer...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.